- Vision-enhancement platform eSight has entered into a strategic partnership with Gentex Corp GNTX to create assistive wearable technology for those with degenerative eyes diseases causing visual impairment. The financial terms were not disclosed.
- eSight uses a combination of hardware and software to enhance vision through a wearable device.
- eSight noted Gentex's capacity and design quality would enable mass-scale production for the next eSight device.
- "While medical scientists research the cause for hundreds of degenerative eye conditions, we're working with eSight to create assistive technology that helps those losing their sight be able to maintain their current lifestyle," said Gentex Chief Technology Officer Neil Boehm.
- Price Action: GNTX shares are trading higher by 0.57% at $35.05 on the last check Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
